Lilly Korea has named Stacie Liu (37), as the new Senior Director of its CardioMetabolic Health Business Unit

On the 1st, Lilly Korea announced that it had appointed Stacie Liu as the Senior Director of its CardioMetabolic Health Business Unit.

In this role, Liu will be responsible for setting and executing the business strategy for Lilly's diabetes and obesity portfolio in Korea, including the company's type 2 diabetes and obesity treatment, Mounjaro.

Lilly's decision is notable in that Liu is a young, foreign, female leader. This is in line with Lilly's culture, which believes in the power of diversity, equity, and inclusion.

As of 2023, one in two (49%) o